Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
基本信息
- 批准号:7868609
- 负责人:
- 金额:$ 26.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-08 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdolescentAdultAgeBasic ScienceBiological MarkersChildChildhoodClinicalClinical DataClinical PharmacologyClinical ResearchClinical ServicesClinical TrialsDevelopmentDiagnosisDisciplineDiseaseDrug KineticsFacultyHealth Services ResearchHereditary DiseaseHuman DevelopmentInstitutionInvestigationLabelLaboratoriesLaboratory ResearchLegal patentMarketingMediator of activation proteinMetabolismMissionNational Institute of Child Health and Human DevelopmentNewborn InfantNursesPharmacistsPharmacodynamicsPharmacologyPhysiciansPhysiologicalProteomicsResearchResearch InfrastructureResearch PersonnelResearch ProposalsResourcesSafetyScientistSiteStudentsTechniquesToxic effectTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesabsorptionbasedesignexperiencenoveloutcome forecastpediatric pharmacologyprogramsresponse
项目摘要
DESCRIPTION (provided by applicant):
This proposal is submitted in response to RFA HD-O3-O01 to obtain support for the KCPCRU, Louisville, KY, as a sites in the NICHD PPRU Network. Long-term proqrammatic objectives of this proposal are: 1) To expand the active participation of the KCPCRU in multi-centered collaborative Clinical trials for the purpose of generating high-quality scientIfic and clinical data to support age-appropriate labeling of new, currently marketed and off-patent pharmacologic agents in newborns, infants and children 2) To further develop the interactive network of basic and clinical scientists at the University of Louisville dedicated to conducting translational research with a focus on characterizing the effect of human development on biologic targets, key pathogenic mediators and physiologic surrogates of pharmacologic response in children 3) To fulfill the educational mission through the development of a multi-disciplinary training program in which physicians, pharmacists and nurses can gain expertise in Pediatric Clinical Pharmacology. These objectives will be accomplished by the following specific aims: 1) To design and conduct collaborative clinical trials within the PPRU network, NICI-ID, NIH and FDA regarding pharmacokinetics, pharmacodynamics, safety, and efficacy of new, currently marketed and off-patent pharmacologic agents in preterm and term newborns, infants, children and adolescents Priority will be given to PPRU network studies 2) To develop an independent "mini-core" of the U of L Proteomics Laboratory that will serve as a complementary resource for network-sponsored trials and support the application of novel proteomic techniques in pediatric pharmacology studies 3) To apply proteomic techniques to identify, develop, validate andlor extrapolate from adult studies on biomarkers of diagnosis, prognosis, efficacy, toxicity and disease activity 4) To characterize the effects of development, disease and genetics on biologic targets, key pathogenic mediators and physiologic surrogates of pharmacologic response in children using a translational science approach 5) To promote the development of students, residents, fellows and junior faculty in the discipline of Pediatric Clinical Pharmacology by providing a multi-faceted training experience encompassing clinical service, research and didactic lectureship. The investigators and applicant institution are caoable of achieving these aims based upon: 1 )an excellent infrastructure to support the clinical and laboratory research components of our program 2)collective expertise in clinical and basic science aspects of pediatric clinical pharmacology research 3)previous and current research accomplishments including those resulting from collaborative investigations with existing PPRU network sites 4) the presence of a multi-disciplinary collaborative network of basic and clinical research scientists dedicated to the conduct of clinical pharmacology studies in children 5)presentation of 4 novel research proposals that speak directly to the program objectives and that are ideally suited for conduct within the PPRU network.
描述(由申请人提供):
该提案是为了响应RFA HD-O3-O01而提交的,以获得NICHD PPRU网络中的KCPCRU,肯塔基州路易斯维尔的KCPCRU。 Long-term proqrammatic objectives of this proposal are: 1) To expand the active participation of the KCPCRU in multi-centered collaborative Clinical trials for the purpose of generating high-quality scientIfic and clinical data to support age-appropriate labeling of new, currently marketed and off-patent pharmacologic agents in newborns, infants and children 2) To further develop the interactive network of basic and clinical scientists at the University of Louisville致力于进行翻译研究,重点是表征人类发展对儿童药理反应的生物学靶标,关键的病原体介质和生理替代物的影响3)3)通过开发多学科培训计划来实现教育使命,从而在该计划中开发医生,药剂师和护士可以在该计划中获得培养精神病学培训的专业知识。这些目标将通过以下具体目的来实现:1)在PPRU网络,NICI-ID,NIH和FDA中设计和进行协作临床试验,涉及药代动力学,新生和非partent newert in New New,销售和不利的药理药物的新生儿和新生儿,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS,PRETUS的优先级别,新生儿的药物学,安全性,安全性和功效L蛋白质组学实验室U的“迷你核”,将作为网络赞助试验的补充资源,并支持新型蛋白质组学技术在小儿药物学研究中的应用3)应用蛋白质组学技术,以识别,发展,发展,验证,验证和验证成人对成人的诊断,预测,预测,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性,毒性的影响,毒性和疾病的影响,毒性和疾病,毒性,疾病的影响,毒性和疾病疾病的影响,有效性,有效性为4,并有效,有效性为疾病。使用转化科学方法对儿童的药理学反应的生物学靶标,关键的致病介质和生理代孕的归因学5)在儿科临床药理学学科中促进学生,居民,研究员和初级教师的发展,通过提供多方面的培训培训经验,包括多方面的培训经验,包括临床上的临床服务,研究,研究和授权。研究人员和申请人机构可以基于以下方面的基础:1)支持我们计划的临床和实验室研究组成部分的良好基础设施2)儿科临床药理学研究的临床和基础科学方面的集体专业知识3)先前和当前的研究成果,包括与现有网络和现有网络的协作研究,包括与现有网络的协作和当前的研究成果,以及乘以PPRU网站的协作,并在现有网络中进行协作4)临床研究科学家致力于在儿童中进行临床药理学研究5)介绍了4项新型研究建议,这些建议直接符合计划目标,并且非常适合PPRU网络中的行为。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study.
- DOI:10.1038/clpt.2011.47
- 发表时间:2011-06
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
Reduced activities of cytochrome P450 1A2 and xanthine oxidase in children with growth hormone deficiency.
- DOI:10.1038/clpt.2008.185
- 发表时间:2008-12
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence.
- DOI:10.1038/clpt.2008.202
- 发表时间:2008-12
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANICE E SULLIVAN其他文献
JANICE E SULLIVAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANICE E SULLIVAN', 18)}}的其他基金
The Kentucky Pediatric Clinical Trials Rural/Urban Partnership
肯塔基州儿科临床试验农村/城市合作伙伴关系
- 批准号:
9461971 - 财政年份:2016
- 资助金额:
$ 26.26万 - 项目类别:
Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
- 批准号:
6868069 - 财政年份:2004
- 资助金额:
$ 26.26万 - 项目类别:
Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
- 批准号:
6727317 - 财政年份:2004
- 资助金额:
$ 26.26万 - 项目类别:
Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
- 批准号:
7169830 - 财政年份:2004
- 资助金额:
$ 26.26万 - 项目类别:
Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
- 批准号:
7345483 - 财政年份:2004
- 资助金额:
$ 26.26万 - 项目类别:
Center for Pediatric Clinical Pharmacology Research
儿科临床药理学研究中心
- 批准号:
7004549 - 财政年份:2004
- 资助金额:
$ 26.26万 - 项目类别:
相似国自然基金
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
大气污染物对青少年心理健康的影响机制研究
- 批准号:42377437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
- 批准号:32300894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 26.26万 - 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 26.26万 - 项目类别: